Technology Entrepreneurship and Commercialization Panel (Non-CME)
June 11, 2021, 12:00 PM – 1:00 PM Eastern Time
SESSION CHAIR: James Wall, MD
Surgeons rely on the tools and technologies at our disposal to optimize surgical interventions for the benefit of patients. Pediatric Surgery is underserved by industry due to small market size and the perception of a higher regulatory risk. Understanding the pathways and barriers in developing health technologies from idea to bedside will help pediatric surgeons to accelerate the pace of new innovations for our patients.
SESSION OBJECTIVES:
- Differentiate opportunity among unmet clinical needs
- Employ strategies to enhance innovative ideation
- Appraise market size and implications for funding
- Understand key risks in the implementation of new technologies
At the conclusion of this session, participants will be able to:
- Know the relative value of unmet clinical needs
- Brainstorm more effectively
- Determine the amount of funding justified by a given market opportunity
- Identify key risks to the deployment of a new technology
OUTLINE:
12:00pm The challenges of developing surgical tools specifically for the pediatric market – Steven Rothenberg, MD
12:05pm Developing surgical tools for adults first with an eye to downsizing – Jim Geiger, MD
12:10pm Building a business around chest wall deformities from the ground up – Marcello Martinez-Ferro, MD and Valaria Ferro
12:15pm The opportunity to innovate for compelling orphan needs – Thomas Krummel, MD
12:20pm Panel Discussion on Identification, Invention, Implementation – James Wall, MD
IRCAD Lecture: The Gastrointestinal Microbiome – What matters to Pediatric Endosurgeons?
June 14, 2021, 12:30 PM – 1:00 PM Eastern Time
Commercial support for this lecture and the IRCAD award is generously provided by KARL STORZ ENDOSCOPY.
All decisions regarding content and speaker(s) have been made by IPEG/Cincinnati Children’s independently.
Keynote Speaker: Holger Till, MD
The gastrointestinal microbiome consists of about 100 trillion live microorganisms building a complex ecosystem within the gut. Without it’s microbiome the human gut would not be able to provide essential functions like nutrient metabolism, structural integrity of the gut mucosal barrier, immunomodulation and protection against pathogens.
Basically the “healthy” and the “unhealthy” microorganisms live in a balanced diversity. Any disbalance contributes to the development of diseases.
For pediatric surgeons this topic seems especially relevant, because normal microbial diversity develops in infancy and factors like neonatal diseases, intensive care, antibiotics and dieting may cause a long-term loss of biodiversity. Moreover disruptions of the intestinal microbiome play an essential role in necrotizing enterocolitis (NEC), small intestinal bacterial overgrowth (SIBO) or Hirschsprung’s associated enterocolitis (HAEC).
This lecture aims to familiarize the pediatric endosurgeons with the role of the microbiome in our field and outline future treatment options that could improve laparoscopic strategies.
SESSION OBJECTIVES:
At the conclusion of this session, participants will be able to:
- Understand the normal gut microbiota, their functional implications in gastrointestinal health and the biological insights that orchestrate these functions.
- Recognize the role of the gastrointestinal microbiome in the development of pediatric surgical diseases like Hirschsprung.
- Appraise the healthy microbiome as a “helper” of endosurgery.
- Recognize novel medical treatments to improve surgical outcome.
OUTLINE:
12:30pm Introduction – Mark Wulkan, MD
12:35pm Keynote Address – Holger Till, MD
Artificial Intelligence for the Pediatric Surgeon Panel
June 14, 2021, 1:30 PM – 2:30 PM Eastern Time
SESSION CHAIR: Seth Goldstein, MD
Surgeons are heavy users of technology and will be at the forefront of healthcare applications of Artificial Intelligence (AI), which is no longer science fiction. This session will be curated for the practicing pediatric surgeon to address the basics of AI, including machine learning and computer vision, to discuss specific applications to contemporary surgical practice, and to broadly describe future trends in medicine.
SESSION OBJECTIVES:
At the conclusion of this session, participants will be able to:
- Classify the subfields of artificial intelligence
- Describe prior and ongoing surgical research that has employed artificial intelligence
- Predict the implications of advances in artificial intelligence to common pediatric surgical care
OUTLINE:
1:30pm The basics of artificial intelligence: machine learning, deep learning, and computer vision – Bethany Slater, MD and Thomas Ward, MD
1:40pm Broad trends in biomedical artificial intelligence – Anthony Chang, MD
1:50pm Panel Discussion – Seth Goldstein, MD
2:00pm What has the computer ever done for me? Existing applications of artificial intelligence in surgery – Anthony Tsai, MD
2:10pm Why we will all log in during time out: Future applications of artificial intelligence in surgery – Amin Madani, MD, PhD
2:20pm Panel Discussion – Seth Goldstein, MD
